Related Experiment Video
Updated: Jan 11, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Dialysis Requirements of Kidney Transplant Recipients During COVID-19
Cihan Uysal1, Tuğba Yılmaz1, Sümeyra Koyuncu2
1Department of Nephrology, Erciyes University Faculty of Medicine, Kayseri, Türkiye.
Insights
Coronavirus Disease 2019 (COVID-19) significantly increases acute kidney injury (AKI) risk in kidney transplant recipients (KTR). Age, anemia, and reduced baseline kidney function predict severe AKI and dialysis needs in these patients.
Area of Science:
- Nephrology
- Transplantation Immunology
- Infectious Diseases
Background:
- Kidney transplant recipients (KTR) face increased Coronavirus Disease 2019 (COVID-19) complications due to immunosuppression and comorbidities.
- Acute kidney injury (AKI) is a common complication of COVID-19, particularly in vulnerable populations like KTR.
Purpose of the Study:
- To investigate the impact of COVID-19 on kidney allograft survival in KTR.
- To identify predictors of AKI and dialysis requirements in KTR following SARS-CoV-2 infection.
Main Methods:
- Retrospective, single-center study of 88 KTR with functioning kidney allografts diagnosed with COVID-19.
- SARS-CoV-2 infection confirmed via PCR and CT scans.
- Analysis of demographic, clinical, and laboratory parameters, including AKI and dialysis needs.
Main Results:
- 70.4% of KTR developed AKI, with 10.2% requiring dialysis.
- Clinical features and inflammatory markers did not significantly predict dialysis needs.
- Logistic regression identified serum protein, albumin, hemoglobin, baseline eGFR, and age as significant predictors of dialysis requirements.
Conclusions:
- Age, anemia, and decreased baseline estimated glomerular filtration rate (eGFR) are associated with severe AKI and dialysis therapy in KTR during COVID-19.
- These factors are crucial for risk stratification and management of KTR with COVID-19.
Objective:
The complications of Coronavirus Disease 2019 (COVID-19) have increased among kidney transplant recipients (KTR) due to chronic immunosuppression and comorbidities. Additionally, acute kidney injury (AKI) is frequently observed during COVID-19. This study aimed to investigate the impact of COVID-19 on kidney allograft survival.
Materials And Methods:
The retrospective, single-center investigation study included 88 patients who had a functioning kidney allograft prior to COVID-19 diagnosis. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was confirmed with a polymerase chain reaction (PCR) test and thoracic computerized tomography. AKI and dialysis requirements were analyzed using laboratory, demographic, and clinical parameters.
Results:
The median age of the patients was 44.5 (34.3-53.8) years, and the median allograft survival was 59.0 (20.8-116.5) months. The mean baseline estimated glomerular filtration rate (eGFR) was 58.2 (21.2-92.8) ml/min/1.73 m2 before the COVID-19 diagnosis. The frequency of AKI was 70.4% (62 patients), and dialysis therapy was required in nine patients (10.2%). The clinical features of COVID-19 and inflammatory markers had no statistical significance in predicting dialysis requirements. However, logistic regression analysis indicated that serum protein level (p=0.034), serum albumin level (p=0.048), hemoglobin (p=0.028), baseline eGFR (p=0.033), and age (p=0.041) were significantly predictive for dialysis requirements.
Conclusion:
Age, anemia, and decreased baseline eGFR are related to severe AKI and dialysis therapy in KTR during COVID-19.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Acute Kidney Injury V: Interprofessional Care

